✦ LIBER ✦

Follow-up of Adverse Drug Reactions from Peginterferon alfa-2b—Ribavirin Therapy

✍ Scribed by Dr. Haleh Bagheri; Dr. Atoussa Fouladi; Dr. Karl Barange; Dr. Maryse Lapeyre-Mestre; Dr. Jean-Louis Payen; Dr. Jean Louis Montastruc; Dr. Jean-Pierre Vinel

Book ID: 115048931
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 446 KB
Volume: 24
Category: Article
ISSN: 0277-0008
DOI: 10.1592/phco.24.16.1546.50947

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

804 SUSTAINED VIROLOGIC RESPONSE AFTER P

804 SUSTAINED VIROLOGIC RESPONSE AFTER PEGINTERFERON ALFA-2B AND RIBAVIRIN TREATMENT PREDICTS LONG-TERM CLEARANCE OF HCV AT 5-YEAR FOLLOW-UP

✍ M. Manns; K.L. Lindsay; S.C. Gordon; P.J. Pockros; D. Haeussinger; S. Hadziyiann 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Effectiveness of peginterferon alfa-2b/r

Effectiveness of peginterferon alfa-2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting

✍ N. Terreni; G. Mandelli; G. Spinzi; G. Minoli 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 112 KB

PG19 COST-UTILITY-ANALYSIS OF PEGINTERFE

PG19 COST-UTILITY-ANALYSIS OF PEGINTERFERON ALFA-2B PLUS RIBAVIRIN VERSUS INTERFERON ALFA-2B PLUS RIBAVIRIN AS INITIAL THERAPY FOR CHINESE NAIVE PATIENTS WITH CHRONIC HEPATITIS C

✍ YH Tarn; WA Lin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

S1001 Clearance of HCV At 5 Year Follow-

S1001 Clearance of HCV At 5 Year Follow-Up for Peginterferon Alfa-2b ± Ribavirin Is Predicted By Sustained Virologic Response At 24 Weeks Post Treatment

✍ Lindsay, Karen; Manns, Michael P.; Gordon, Stuart C.; Pockros, Paul; Haussinger, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Prediction of response to peginterferon-

Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b

✍ Yoshimasa Hashimoto; Hidenori Ochi; Hiromi Abe; Yasufumi Hayashida; Masataka Tsu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

## Abstract Variation at the IL‐28B locus was recently reported to be a significant predictive factor of viral response to pegylated‐interferon plus ribavirin combination therapy against chronic hepatitis C. Predictive factors for the effect of therapy, including IL‐28B polymorphism rs8099917 and v

Viral kinetics in genotype 1 chronic hep

Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

✍ Maria Buti; Francisco Sanchez-Avila; Yoav Lurie; Carlos Stalgis; Auristela Valdé 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB